The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.
Search results for: opioids
What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics
The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica
The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Pain in Rheumatoid Arthritis
Out from the shadow of inflammation
Revising Fibromyalgia: One Year Later
The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care